Trial intelligence / Profile preview

Lidoderm as Add-On to Gabapentin for Neuropathic Pain or Low Back Pain

NCT00904020Phase 4Completed

Sponsor
Endo International plc
Start
Jun 2002
Primary completion
Nov 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lidocaine 10% oropharyngeal spray in postherpetic neuralgia (PHN), diabetic neuropathy, low back pain (LBP), sponsored by Endo International plc. Started Jun 2002; status: completed.

02

Drugs

lidocaine 10% oropharyngeal spray
03

Conditions

postherpetic neuralgia (PHN)diabetic neuropathylow back pain (LBP)

Beyond the preview

Go deeper on NCT00904020.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00904020.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call